Recruiting Pulmonary Embolism Studies in Lancaster
About Pulmonary Embolism Clinical Trials in Lancaster
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 1 pulmonary embolism clinical trials recruiting participants in Lancaster, PA. These studies are seeking a combined 288 participants. Research is being sponsored by Novo Nordisk A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Lancaster — FAQ
Are there pulmonary embolism clinical trials in Lancaster?
Yes, there are 1 pulmonary embolism clinical trials currently recruiting in Lancaster, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lancaster?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you about next steps.
Are clinical trials in Lancaster free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lancaster studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 1 active trials in Lancaster are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov